Cargando…
Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines
Due to local variation in the antigenicity of the agent of Lyme disease (Borrelia burgdorferi), a vaccine derived from any one isolate of this spirochete may fail to protect against the heterogeneous population of organisms that may be present in an enzootic focus. Accordingly, we determined whether...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2191140/ https://www.ncbi.nlm.nih.gov/pubmed/8340764 |
Ejemplares similares
-
Pilot Study of Immunoblots with Recombinant Borrelia burgdorferi Antigens for Laboratory Diagnosis of Lyme Disease
por: Liu, Song, et al.
Publicado: (2018) -
Vaccination against Lyme disease caused by diverse Borrelia burgdorferi
Publicado: (1995) -
Borrelia burgdorferi (Lyme Disease)
por: Shapiro, Eugene D.
Publicado: (2014) -
Pathogenicity and virulence of Borrelia burgdorferi
por: Strnad, Martin, et al.
Publicado: (2023) -
Borrelia burgdorferi and Borrelia miyamotoi in Atlantic Canadian wildlife
por: Zinck, Christopher B., et al.
Publicado: (2022)